Russell Frank Company’s AbbVie ABBV Stock Holding History

Russell Frank Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$78.6M	Sell	1,376,008 -263,402	-16%	-$14.7M	0.14%	163
2015 Q4	$98M	Buy	1,639,410 +206,309	+14%	+$11.9M	0.17%	134
2015 Q3	$78M	Sell	1,433,101 -423,389	-23%	-$27.6M	0.15%	145
2015 Q2	$125M	Buy	1,856,490 +479,627	+35%	+$31.3M	0.2%	102
2015 Q1	$80.6M	Buy	1,376,863 +966,262	+235%	+$58.4M	0.15%	160
2014 Q4	$27.2M	Sell	410,601 -110,042	-21%	-$6.94M	0.05%	445
2014 Q3	$30.1M	Sell	520,643 -701,172	-57%	-$38.9M	0.05%	392
2014 Q2	$64M	Buy	1,221,815 +248,603	+26%	+$13M	0.11%	211
2014 Q1	$50M	Buy	973,212 +186,581	+24%	+$9.43M	0.09%	262
2013 Q4	$38.7M	Sell	786,631 -708,066	-47%	-$34.8M	0.07%	313
2013 Q3	$66.9M	Sell	1,494,697 -891,007	-37%	-$39.5M	0.12%	194
2013 Q2	$103M	Buy	+2,385,704	New	+$104M	0.19%	117

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company's ABBV Position: Q1 2016 in Review

Russell Frank Company reduced its AbbVie (ABBV) stake by 16% in Q1 2016, selling an estimated $14.7M and leaving 1,376,008 shares worth $78.6M. The position accounts for 0.14% of the portfolio, ranked #163.

Russell Frank Company first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. The position peaked at $125M in Q2 2015. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Russell Frank Company held 1,376,008 shares of AbbVie worth $78.6M as of Q1 2016.
Russell Frank Company sold 263,402 AbbVie shares in Q1 2016, an estimated $14.7M.
AbbVie made up 0.14% of Russell Frank Company's portfolio in Q1 2016, its #163 holding.
Russell Frank Company first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's AbbVie position peaked at $125M in Q2 2015.
1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.